International Clinical Trial: A Research Study on How NNC0487-0111, a New Medicine, Works in Chinese Participants When Injected Under the Skin

Geneva, Aug. 29 -- International Clinical Trials Registry received information related to the study (NCT07121153) titled 'A Research Study on How NNC0487-0111, a New Medicine, Works in Chinese Participants When Injected Under the Skin' on Aug. 7.

Study Type: Interventional

Study Design: Allocation: Randomized. Intervention model: Sequential Assignment. Primary purpose: Treatment. Masking: Double (Participant, Investigator).

Primary Sponsor: Novo Nordisk A/S

Condition: Overweight Obesity

Intervention: Drug: NNC0487-0111 A

Recruitment Status: Recruiting

Phase: Phase 1

Date of First Enrollment: August 11, 2025

Target Sample Size: 36

Countries of Recruitment: China

To know more, visit https://clinicaltrials.gov/ct2/show/NCT0...